<DOC>
	<DOCNO>NCT00006462</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness gemcitabine treat child relapse refractory acute lymphoblastic leukemia acute myelogenous leukemia .</brief_summary>
	<brief_title>Gemcitabine Treating Children With Relapsed Refractory Acute Lymphoblastic Leukemia Acute Myelogenous Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate child relapse refractory acute lymphoblastic leukemia acute myelogenous leukemia treat gemcitabine . - Assess toxicity regimen patient . OUTLINE : This multicenter study . Patients stratify accord disease histology ( acute lymphoblastic leukemia v acute myelogenous leukemia ) . Patients receive gemcitabine IV 6 hour weekly 3 week . Treatment repeat every 4 week maximum 2 course absence disease progression unacceptable toxicity . PROJECTED ACCRUAL : Approximately 10-20 patient accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis relapse acute lymphoblastic leukemia acute myelogenous leukemia M3 marrow ( least 25 % blast bone marrow aspirate ) Refractory conventional therapy PATIENT CHARACTERISTICS : Age : 21 diagnosis Performance status : ECOG 02 OR Zubrod 02 Life expectancy : At least 2 month Hematopoietic : Not specify Hepatic : Bilirubin normal SGOT SGPT great 2.5 time upper limit normal Renal : Creatinine normal OR Creatinine clearance radioisotope glomerular filtration rate least 70 mL/min Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent immunomodulating agent Chemotherapy : At least 2 week since prior chemotherapy No concurrent chemotherapy cancer Endocrine therapy : No concurrent corticosteroids except treatment adrenal crisis suppress pituitary/adrenal response Concurrent lowdose hydrocortisone ( le 100 mg/m2 ) allow allergic reaction amphotericin transfusion Radiotherapy : Concurrent radiotherapy localize painful lesion allow Surgery : Not specify Other : Recovered prior therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>recurrent childhood acute lymphoblastic leukemia</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
</DOC>